KAYLYN VONGLAHN: Open Payments
NPI 1649554569 · CONIFER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 33 payments from 16 companies in 2025. Trend: 2023 $156 · 2024 $372 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $116 |
| ABBVIE INC. | 4 | $78 |
| PFIZER INC. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $48 |
| Grifols USA, LLC | 2 | $46 |
| Hologic Sales and Service, LLC | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Organon LLC | 2 | $28 |
Products named: SHINGRIX, REXULTI, NURTEC ODT, UBRELVY, MOUNJARO, Prolastin-C Liquid, APTIMA, CAPLYTA.
Industry payments across CO — which companies pay providers there.
